Hematopoietic stem cell transplantation (HSCT), also known as bone marrow transplantation, provides life-saving treatment for various hematological malignancies and non-malignant disorders. It involves transplanting healthy hematopoietic stem cells to restore bone marrow and immune function in patients who receive high-dose chemotherapy and/or radiation as part of their cancer treatment. This revolutionary treatment has the potential to cure various forms of blood cancer and some genetic, metabolic, and immune disorders by replacing defective or diseased bone marrow with healthy cells.
The global Hematopoietic Stem Cell Transplantation (HSCT) Market is estimated to be valued at US$ 2.88 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Propelled by increasing adoption of innovative transplantation methods, the hematopoietic stem cell transplantation market is expected to exhibit strong growth over the forecast period. One of the key trends fueling market growth is the increasing preference for peripheral blood stem cells over traditional bone marrow transplantation. Peripheral blood stem cell transplantation is a major improvement over traditional bone marrow transplantation as it is less invasive, associated with a faster engraftment and recovery time for patients, and has a higher chance of finding a matched donor. It has emerged as the stem cell source of choice for both autologous and allogeneic transplantations. The development of novel transplantation procedures such as double umbilical cord blood transplantation and reduced-intensity conditioning regimens is also expected to boost the demand for HSCT over the next few years.
SWOT Analysis
Strengths: HSCT has strong curative potential for various life-threatening hematologic malignancies and genetic disorders. It can offer higher survival and cure rates compared to other treatment options.
Weaknesses: HSCT poses life-threatening risks such as graft-versus-host disease. There is a shortage of suitable stem cell donors. Collection of stem cells from umbilical cord blood also has certain limitations.
Opportunities: Developing alternative stem cell sources such as induced pluripotent stem cells and gene-edited stem cells can address some of the current challenges and expand indications. Growing public and private funding is supporting research in this area.
Threats: Stringent regulatory approval pathways can delay market access to novel technologies. COVID-19 pandemic has impacted availability of resources for HSCT procedures in the short term. Privacy and security issues related to stem cell data pose regulatory compliance challenges.
Key Takeaways
The global Hematopoietic Stem Cell Transplantation (HSCT) market is expected to witness high growth. The global hematopoietic stem cell transplantation (HSCT) Market is estimated to be valued at US$ 2.88 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.
Regional analysis: North America is currently dominating the global HSCT market due to high adoption rate and continuous investments in stem cell research. Asia Pacific region is expected to grow at the fastest pace during forecast period driven by increasing healthcare spending, patient awareness and growing incidence of target diseases in countries like China and India.
Key players: Key players operating in the HSCT market are Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Kiadis Pharma, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio, Inc., Talaris Therapeutics, Inc., Marker Therapeutics Inc., Stempeutics Research Pvt Ltd., CBR Systems Inc., Priothera Ltd., Eurobio Scientific Group, Otsuka America Pharmaceutical, Inc., Pfizer Inc., Sanofi, FUJIFILM Holdings Corporation.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.